Apogee Therapeutics, Inc.
APGE
Revenue
0.00
0.000.00%
-Assets
753.95M
▼-22.34M▼-2.88%
3 Months ChangeLiabilities
37.16M
▼-4.73M▼-11.29%
3 Months ChangeFree Cash Flow
-31.99M
▼-31.99M-∞%
-Revenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-24
Form 8-K
ID: 0001104659-24-111027
2024-08-19
Form 8-K
ID: 0001104659-24-090690
2024-08-12
Form 10-Q
ID: 0000950170-24-095053
2024-08-12
Form 8-K
ID: 0001104659-24-088029
2024-06-07
Form 8-K
ID: 0001104659-24-069619
2024-05-28
Form 8-K
ID: 0001104659-24-065322
2024-05-15
Form 8-K
ID: 0001104659-24-061998
2024-05-13
Form 10-Q
ID: 0001558370-24-007861
2024-05-13
Form 8-K
ID: 0001104659-24-060195
2024-03-25
Form 8-K
ID: 0001104659-24-038161